1.
Antigen-specific enhancement of natural human IgG antibodies to phosphatidylcholine, phosphatidylglycerol, phosphatidylinositol-4-phosphate, cholesterol, and lipid A by a liposomal...
by Matyas, Gary R
Vaccine, 18 July 2011, Vol.29(32), pp.5137-5144
2.
Differential immune responses to HIV-1 envelope protein induced by liposomal adjuvant formulations containing monophosphoryl lipid A with or without QS21
by Beck, Zoltan
Vaccine, 13 October 2015, Vol.33(42), pp.5578-5587
3.
Development of a combination heroin-HIV vaccine
by Matyas, Gary R
Drug and Alcohol Dependence, 01 February 2017, Vol.171, pp.e133-e134
4.
Hapten selection for heroin vaccines
by Matyas, Gary R
Drug and Alcohol Dependence, 01 November 2015, Vol.156, pp.e143-e143
5.
A simple nonradioactive method for the determination of the binding affinities of antibodies induced by hapten bioconjugates for drugs of abuse
by Torres, Oscar
Analytical and Bioanalytical Chemistry, 2016, Vol.408(4), pp.1191-1204
6.
A rapid solution-based method for determining the affinity of heroin hapten-induced antibodies to heroin, its metabolites, and other opioids
by Torres, Oscar
Analytical and Bioanalytical Chemistry, 2018, Vol.410(16), pp.3885-3903
7.
Platelets and erythrocyte-bound platelets bind infectious HIV-1 in plasma of chronically infected patients
by Zoltan Beck
PLoS ONE, 01 January 2013, Vol.8(11), p.e81002
8.
Skin immunization made possible by cholera toxin
by Gregory M. Glenn
Nature, 1998, Vol.391(6670), p.851
9.
Liposomes containing lipid A: an effective, safe, generic adjuvant system for synthetic vaccines
by Alving, Carl R
Expert Review of Vaccines, 01 June 2012, Vol.11(6), pp.733-744
10.
A Stable Heroin Analogue That Can Serve as a Vaccine Hapten to Induce Antibodies That Block the Effects of Heroin and Its Metabolites in Rodents and That Cross-React Immunologicall...
by Sulima, Agnieszka
Journal of medicinal chemistry, 11 January 2018, Vol.61(1), pp.329-343
11.
Liposome-Encapsulated Human Immunodeficiency Virus-1 gp120 Induces Potent V1V2-Specific Antibodies in Humans
by Rao, Mangala
The Journal of Infectious Diseases, 2018, Vol. 218(10), pp.1541-1550
12.
Characterization and optimization of heroin hapten-BSA conjugates: method development for the synthesis of reproducible hapten-based vaccines
by Torres, Oscar
Analytical and Bioanalytical Chemistry, 2014, Vol.406(24), pp.5927-5937
13.
Detection of liposomal cholesterol and monophosphoryl lipid A by QS-21 saponin and Limulus polyphemus amebocyte lysate
by Beck, Zoltan
BBA - Biomembranes, March 2015, Vol.1848(3), pp.775-780
14.
An anti-phosphoinositide-specific monoclonal antibody that neutralizes HIV-1 infection of human monocyte-derived macrophages
by Jobe, Ousman
Virology, 01 September 2012, Vol.430(2), pp.110-119
15.
Adjuvants for vaccines to drugs of abuse and addiction
by Alving, Carl R
Vaccine, 22 September 2014, Vol.32(42), pp.5382-5389
16.
Self-Assembling Protein Nanoparticles: implications for HIV-1 vaccine development.
by Karch, Christopher P
Nanomedicine (London, England), September 2018, Vol.13(17), pp.2121-2125
17.
The importance of antibody isotype in HIV-1 virus capture assay and in TZM-bl neutralization.
by Peachman, Kristina K
Viral immunology, December 2010, Vol.23(6), pp.627-632
18.
Antibodies to squalene in US Navy Persian Gulf War veterans with chronic multisymptom illness
by Phillips, Christopher J
Vaccine, 12 June 2009, Vol.27(29), pp.3921-3926
19.
Infection of human peripheral blood mononuclear cells by erythrocyte-bound HIV-1: Effects of antibodies and complement
by Beck, Zoltan
Virology, 2011, Vol.412(2), pp.441-447
20.
Inhibition of HIV-1 infection of peripheral blood mononuclear cells by a monoclonal antibody that binds to phosphoinositides and induces secretion of β-chemokines
by Matyas, Gary R
Biochemical and Biophysical Research Communications, 26 November 2010, Vol.402(4), pp.808-812
